CIDRAP newsletters options
FDA experts will likely meet Dec 17 to review safety and efficacy data.
A group of clinicians and researchers with expertise in pediatric healthcare-associated infections (HAIs) and antimicrobial stewardship has developed a list of high-priority research topics for improving health outcomes in children.
A small German autopsy study of COVID-19 victims in Nature Neuroscience today demonstrates the presence of SARS-CoV-2—the virus that causes COVID-19—in nasal structures and the brain, suggesting that the virus crosses into the central nervous system (CNS) via nasal surfaces that contain nerve endings for smell.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Nov 23
For the first time since the start of the pandemic, the US added more than 1 million cases in each of the past 2 weeks.
Through Sep 24, the CDC says, seroprevalence rates ranged from 0% to 23%.
"There are no compelling data to suggest that hydroxychloroquine is effective."
A study of SARS-CoV-2–positive Canadian children in CMAJ yesterday showed that 64.1% of children were symptomatic, with loss of taste or smell, stomach upset, headache, and fever most predictive of infection.
While both North America and Europe have detected chronic wasting disease (CWD) in cervids such as deer, the two continental strains are distinct, reports a study yesterday in Proceedings of the National Academy of Sciences (PNAS).
States that took aggressive steps are seeing results, White House experts say.
The artificial intelligence platform detected COVID-19 10 times faster and was a bit more accurate.
The number of drug suppliers able to deliver at least 80% of their products on time dropped 16 percentage points.
Chronic wasting disease (CWD), a fatal neurologic prion disease that affects members of the deer family, was detected in two cervids in Montana and Virginia. In 2019, 144 cases of CWD were reported in Montana and 1 case was reported in Virginia.
A PLOS One study yesterday showed a 43% overall mortality rate for mechanically ventilated COVID-19 patients, with an even higher risk of death for patients of advanced age.
Combined data show 70% efficacy, but it was 90% when the first dose was halved.
The biggest concern is what Thanksgiving gatherings will mean for hospitals, some of which are already buckling.
The report details obstacles for more than 12 million English language learners and special education students.
One expert says Europe could experience a third wave if it repeats mistakes it made after the first wave.
Racial minorities and other at-risk children appear to have more serious outcomes.
A Dutch study late last week found reduced lung capacity in 42% of COVID-19 patients 3 months after recovery, with many patients reporting severe problems with fatigue, functional impairment, and quality of life (QoL).
